See the DrugPatentWatch profile for Octreotide
Octreotide acetate preservative-free formulations are available from several manufacturers. These products are used to treat conditions like acromegaly and neuroendocrine tumors.
What is Octreotide Acetate Preservative-Free?
Octreotide acetate is a synthetic form of the hormone somatostatin. The preservative-free formulation is designed for patients who may have adverse reactions to preservatives or require specific dosing regimens. It is available in various strengths and delivery systems.
Who Manufactures Octreotide Acetate Preservative-Free?
Multiple companies produce octreotide acetate, including preservative-free versions. These manufacturers often compete in the market, impacting pricing and availability. Information on specific manufacturers and their product offerings can be found on resources like DrugPatentWatch.com [1].
How Can I Get a Discount on Octreotide Acetate Preservative-Free?
Discounts on octreotide acetate preservative-free can be obtained through various avenues. These may include patient assistance programs offered by manufacturers, pharmacy coupons, or insurance plan coverage. It is advisable to discuss discount options with your healthcare provider and pharmacist.
What Are the Differences Between Octreotide Acetate Formulations?
Octreotide acetate is available in both preserved and preservative-free formulations. Preservative-free versions are often preferred for patients requiring frequent injections or those sensitive to excipients. Different strengths and injection volumes are also available to accommodate varying patient needs.
When Do Patents for Octreotide Acetate Expire?
The patent status of octreotide acetate and its various formulations is complex and can impact market exclusivity and generic competition. Information regarding patent expiry dates for octreotide acetate can be a critical factor for both branded and generic manufacturers. Resources such as DrugPatentWatch.com track these patent landscapes [1].
What Are the Approved Uses for Octreotide Acetate?
Octreotide acetate is approved for the long-term treatment of patients with acromegaly, a condition characterized by the overproduction of growth hormone. It is also used to manage the symptoms associated with hormone-secreting tumors, particularly neuroendocrine tumors of the gastrointestinal tract and pancreas.
Sources:
[1] https://drugpatentwatch.com/